WWB

24.2851.15%
KA

Kevin Andrew Harris

Chief Operating Officer

Mr. Kevin Andrew Harris, M.B.A., is Chief Operating Officer of Windward Bio AG and Windward Bio Group AG from January 2025. Mr. Harris was Chief Commercial Officer at VectivBio Holding AG since November 2019 from November 2019 to July 2023. Mr. Harris has over 24 years of biopharma leadership experience and expertise in commercialization strategy. Prior to joining VectivBio Holding AG, Mr. Harris served as Group Vice President of Global Product Strategy from January 2017 through October 2019 at Incyte Corporation. In this role, Mr. Harris established the function and built global product strategy and market development plans for over 15 immunotherapies and targeted agents and was also responsible for global value, access and pricing strategy. From June 2015 to January 2017, he served as Vice President of Global Product Strategy. Prior to this role, he served as Vice President of Commercial from February 2009 to June 2015 at Incyte Corporation. In this position, he played an integral role launching Jakafi (ruxolitinib) and building out the commercial organization. Mr. Harris received an M.B.A., with distinction, from Kellogg Graduate School of Management at Northwestern University and a B.A. in biology from Cornell University.

Positions